WYPR
October 15, 2024
By Scott Maucione
Excerpt:
“Next week, the Maryland General Assembly’s Legislative Policy Committee will vote on the Maryland Prescription Drug Affordability’s plan for setting upper payment limits with drug companies.
Those limits allow the state to negotiate with companies that are charging exorbitant prices for common drugs for insurance plans run by the state.
The Board finished its final plan on setting upper payment limits after years of work in September. By law, the Legislative Policy Committee must vote on the plan within 45 days of submission.
“We are hopeful that the legislative policy committee will approve it, and once that happens, we are hopeful that the board will use that authority to make high-cost drugs more affordable for state and local governments,” said Vincent DeMarco, president of Maryland Healthcare for All!, a drug affordability group.”
Read the full article at wypr.org.
Last modified: October 16, 2024
